BPTH Bio Stock Forecast Period (n+7) 31 Dec 2020


Stock Forecast


As of Thu Dec 31 2020 00:00:02 GMT+0000 (Coordinated Universal Time) shares of BPTH Bio 4.3 percentage change in price since the previous day's close. Around 255827 of 4542000 changed hand on the market. The Stock opened at 3.55 with high and low of 3.47 and 3.68 respectively. The price/earnings ratio is: - and earning per share is -3. The stock quoted a 52 week high and low of 2.92 and 8.49 respectively.

BOSTON (AI Forecast Terminal) Thu, Dec 31, '20 AI Forecast today took the forecast actions: In the context of stock price realization of BPTH Bio is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+7) for BPTH Bio as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of BPTH Bio as below:

BPTH Bio Credit Rating Overview


We rerate BPTH Bio because of a weaker market position, higher risk, or more confidence-sensitive mix of business is only partially offset by any strengths, and this leads us to expect weaker revenue stability relative to peers, thus demonstrating modest incremental risk above what is captured in the anchor. We use econometric methods for period (n+7) simulate with Moving Average Convergence Divergence (MACD) Independent T-Test. Reference code is: 1434. Beta DRL value REG 31 Rational Demand Factor LD 5114.1888. We do not assume future debt refinancing or the rolling over of CP, regardless of the company's perceived credit strength or issuer credit rating. For instance, even for investment-grade issuers, we do not assume future debt maturities are refinanced with potential uncommitted capital raises. We could, however, consider a shorter time horizon. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for BPTH Bio as below:
Frequently Asked QuestionsQ: What is BPTH Bio stock symbol?
A: BPTH Bio stock referred as NASDAQ:BPTH
Q: What is BPTH Bio stock price?
A: On share of BPTH Bio stock can currently be purchased for approximately 3.64
Q: Do analysts recommend investors buy shares of BPTH Bio ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for BPTH Bio at daily forecast section
Q: What is the earning per share of BPTH Bio ?
A: The earning per share of BPTH Bio is -3
Q: What is the market capitalization of BPTH Bio ?
A: The market capitalization of BPTH Bio is 16532880
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com